Beyond Air, Inc. (XAIR) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Beyond Air, Inc. (formerly AIT Therapeutics, Inc.) on July 15, 2019. The Company is incorporated in Delaware and its common stock trades on The Nasdaq Capital Market. The report identifies the Company as an emerging growth company.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event notification and does not contain financial statements or performance metrics.
Material Changes
The primary material change reported is the rebranding of the Company and its securities:
- Stock Symbol Change: The trading symbol for the Company's common stock changed from "AITB" to "XAIR" effective July 15, 2019.
- Corporate Name: The Company is now operating as Beyond Air, Inc., having previously been known as AIT Therapeutics, Inc.
- Listing Status: The common stock continues to be listed on the Nasdaq Capital Market.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management outlook, specific risks, contingencies, or unusual items beyond the administrative change of the stock symbol. The report incorporates a press release by reference but does not detail its contents within the body of the 8-K.
Key Facts for Investor Verification
- Verify the new ticker symbol "XAIR" on trading platforms effective July 15, 2019.
- Confirm the Company's strategic pivot from AIT Therapeutics to Beyond Air, Inc. by reviewing the attached press release (Exhibit 99.1).
- Check subsequent filings for financial data, as this 8-K contains no financial performance metrics.